Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-17 Grunberg Gregory Director Grant or award +20,000 40,000
2020-06-25 Grunberg Gregory Director Grant or award +20,000 20,000
2020-03-13 Grunberg Gregory Director Purchase +2,534,854 $7.89 $20.0M 2,534,854
2019-06-05 Grunberg Gregory Director Grant or award · Stock Option (right to buy) +21,000 21,000
2018-10-05 Grunberg Gregory Director Purchase +606,060 $8.25 $5.0M 2,877,006
2018-06-12 Grunberg Gregory Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-25 Grunberg Gregory Director Conversion +2,055,946 2,055,946
2017-07-25 Grunberg Gregory Director Purchase +215,000 $15.00 $3.2M 2,270,946
2017-07-25 Grunberg Gregory Director Conversion · Series C Preferred Stock −10,707,985 0
2017-07-19 Grunberg Gregory Director Grant or award · Stock Option (right to buy) +12,960 12,960

Page 1 of 1 · 10 trades